Washington University in St. Louis (WU)
We are focused on understanding how the tumor microenvironment (TME) impacts the progression and response to therapy in lung cancer. Our research focuses on the interactions between tumor cells and tumor-associated stromal cells, such as fibroblasts, that regulate response to therapy, including immune-based therapies.